ERBB2 and neoplasm: The pathological examination of the biopsy systematically includes evaluation of the prognostic and predictive factors such as tumor size, histoprognostic grade Scarff-Bloom-Richardson I to III; mitotic index or Ki67; evaluation of ERα and PR status; and the search for HER2 amplification.